Drugs / ACTH
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02226341 Comparator | Oct 2014 → Jan 2024 | lupus nephritis | Columbia University | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02226341 ↗ |
| Action | Activate | “ACTH binding to melanocortin 2 receptor subtype (MC2R) on the adrenal cortex stimulates the production of cortisol that reduces inflammation in the kidney.” NCT02226341 ↗ |
| Route | Subcutaneous | “80 U biw, subcutaneous” NCT02226341 ↗ |
| Target | MC2R | “ACTH binding to melanocortin 2 receptor subtype (MC2R)” NCT02226341 ↗ |